NASDAQ: ELTX - Elicio Therapeutics, Inc.

六个月盈利: -43.65%
部门: Healthcare

促销时间表 Elicio Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers.

更多详情
It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0122
EV/EBITDA 0.4857
Цена ао 7.1
ISIN US28657F1030
Сайт https://elicio.com
P/BV -0.1211
Число акций ао 0.0096 млрд
Выручка 0.0029
P/S 3.24
Валюта usd
IPO date 2021-02-05
Sector Health Care
Industry Pharmaceuticals
Валюта отчета usd
每日价格变化: -3.17% (5.04)
每周价格变化: +0.2053% (4.87)
每月价格变化: +25.45% (3.89)
3个月内价格变化: +32.97% (3.67)
六个月内的价格变化: -43.65% (8.66)
每年价格变化: -34.85% (7.49)
3年内价格变化: -52.85% (10.35)
年初以来价格变化: -25.04% (6.51)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 3.16 5
P/E 0 0
EV/EBITDA -0.8654 0
全部的: 3.13

效率

姓名 意义 年级
ROA, % -129.65 0
ROE, % -309.46 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.2001 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 875.86 10
盈利能力 Ebitda, % 183.4 10
盈利能力 EPS, % 364.05 10
全部的: 10
更多详情

机构 体积 分享, %
Vanguard Group Inc 174894 1.71
CM Management, LLC 50000 0.49
Geode Capital Management, LLC 44344 0.43
Renaissance Technologies, LLC 16466 0.16
Citadel Advisors Llc 14005 0.14
Meyer Handelman Co 13899 0.14
Bridgeway Capital Management, Inc. 12500 0.12
Tower Research Capital LLC (TRC) 2045 0.02
Steward Partners Investment Advisory, LLC 1554 0.02
Bank of America Corporation 1149 0.01

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.00961 36.318555985322 1.54048



导师 职称 支付 出生年份
Mr. Robert T. Connelly CEO, President & Director 612k 1960 (64 年)
Dr. Christopher M. Haqq M.D., Ph.D. Executive VP, Head of Research & Development and Chief Medical Officer 589k 1966 (58 年)
Prof. Darrell J. Irvine Ph.D. Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board N/A
Mr. Michael DiVecchia Senior Vice President of Operations & Human Resources N/A
Dr. Peter DeMuth Ph.D. Chief Scientific Officer N/A 1986 (38 年)
Ms. Esther Welkowsky Senior Vice President of Clinical Development N/A
Ms. Joy Seymour VP & Head of Regulatory Affairs N/A
Ms. Megan C. Filoon General Counsel, Secretary & Compliance Officer N/A
Dr. Thian Kheoh Ph.D. Senior Vice President of Biometrics N/A

地址: United States, Boston. MA, 451 D Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://elicio.com